Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
ProShares Ultra Nasdaq Biotechnology
(NASDAQ:BIB)
Intraday
$50.23
1.29
[2.64%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$50.23
1.29
[2.64%]
Last update: 4:07PM
Get Real Time Here
Get Report
Watch
Overview
News
Dividends
Short Interest
Latest News for ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)
ProShares Ultra Nasdaq Biotechnology (NASDAQ: BIB)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, February 20, 2023
Man in Germany Cured of HIV After Undergoing Stem Cell Transplant, According to Report in Nature Medicine
Charles Gross
-
Feb 20, 2023, 1:14PM
Friday, December 17, 2021
Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index
Nina Zdinjak
-
Dec 17, 2021, 11:15AM
Monday, March 09, 2020
Shares of several Chinese companies are trading lower as the coronavirus continues to spread within China and around the world. The virus has heavily disrupted economic activity in China and has weighed on global macro outlook.
Benzinga Newsdesk
-
Mar 9, 2020, 12:55PM
Tuesday, August 01, 2017
3 ETFs To Watch Out For On Biotech Earnings
Benzinga
-
Aug 1, 2017, 12:41PM
Monday, October 17, 2016
Exclusive: SunTrust Managing Director Goes Over Sarepta Therapeutics' Story
Benzinga
-
Oct 17, 2016, 8:49AM
Thursday, October 13, 2016
Exclusive: SunTrust Managing Director Discusses Bluebird Bio, A Leader In Gene Therapy
Benzinga
-
Oct 13, 2016, 9:51AM
Wednesday, June 22, 2016
Biotechs Are Ripping Following IPAB Ruling
Benzinga
-
Jun 22, 2016, 11:31AM
Tuesday, March 15, 2016
New Study Suggests Drug Prices Have Doubled Since 2011: What's It Mean For The Market?
Benzinga
-
Mar 15, 2016, 11:36AM
Tuesday, June 23, 2015
ProShares Releases 2 New Leveraged Biotech ETFs
Benzinga
-
Jun 23, 2015, 3:38PM
Wednesday, August 06, 2014
Why Investors Should Closely Watch Celgene
Benzinga
-
Aug 6, 2014, 4:53PM
Thursday, April 24, 2014
UCB Sales Rise in Q1 - Analyst Blog
Benzinga
-
Apr 24, 2014, 5:01PM
Saturday, October 05, 2013
Seven ETFs On A Roll (BIB, SOCL, TAN)
Benzinga
-
Oct 5, 2013, 10:55AM
Friday, March 08, 2013
If Stocks Keep Soaring, Get to Know These Leveraged ETFs
Benzinga
-
Mar 8, 2013, 2:16PM
Friday, September 21, 2012
ProShares to Split 2, Reverse Split 9 ETFs
Benzinga
-
Sep 21, 2012, 8:59AM
Friday, July 13, 2012
Low Volume, High Returns for These ETFs (BIB, FHC, DRW)
Benzinga
-
Jul 13, 2012, 3:25PM
Wednesday, May 02, 2012
Nine ETFs on a Roll (DRN, TQQQ, BIB, BGU)
Benzinga
-
May 2, 2012, 7:09AM
